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Background: Cardiovascular disease is the main cause of mortality in dialysis patients.
Carotid intima–media thickness (CIMT) is used as a surrogate marker of early
atherosclerosis. Atherosclerosis can cause vascular access failure. The purpose of this
study was to deﬁne the clinical features of atherosclerosis in hemodialysis patients
based on CIMT and to deﬁne the relationship between CIMT and access failure.
Methods: In this cross-sectional study, the CIMT of 60 patients on hemodialysis was
examined using B-mode Doppler ultrasonography between May 2012 and November
2012. Carotid atherosclerosis was deﬁned as a CIMTZ0.9 mm or the incidence of
atherosclerotic plaques.
Results: The patients’ mean age was 54.5710.6 years, and 60% of the patients were
male. The CIMT was 0.8170.47 mm (range, 0.35–2.50 mm). The group with athero-
sclerosis was characterized by older age compared with those without atherosclerosis.
Patients with atherosclerosis showed much shorter durations of access patency than
their counterparts in the nonatherosclerosis group (hazard ratio, 2.822; 95% conﬁdence
interval, 1.113–7.156; P¼0.029). Moreover, being overweight was associated with a
2.47-fold (95% conﬁdence interval, 1.101–5.548) increased primary access failure.
Conclusion: This study shows that atherosclerosis is associated with older age.
Patients who are overweight and have atherosclerosis may have shortened access
patency.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Cardiovascular disease is a principal cause of morbidity and
mortality in dialysis patients. The United States Renal Data
System reports that cardiovascular disease accounts for
30–40% of all deaths [1]. Cardiovascular disease ranks as the
most common cause (46.8%) of death among Korean dialysisn Society of Nephrology. Publi
c-nd/4.0/).
y, Department of Internal
Hospital, Jomaru-ro 170,patients according to the registry committee of the Korean
Society of Nephrology in 2011 [2]. Atherosclerosis is a condi-
tion in which an artery wall thickens as a result of the
accumulation of fatty materials. Atherosclerosis is the domi-
nant cause of cardiovascular disease including myocardial
infarction, heart failure, stroke, and claudication [3]. Kawagishi
et al [4] reported that hemodialysis (HD) patients show
advanced atherosclerosis in the carotid artery compared with
age-matched healthy controls. Assessment of the carotid
intima–media thickness (CIMT) using B-mode ultrasound is a
useful clinical tool for the measurement of atherosclerosis. A
CIMTZ0.9 mm has been shown to be a marker of generalized
atherosclerosis and is associated with cardiovascular riskshed by Elsevier. This is an open access article under the CC BY-NC-ND
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exhibit increased intima–media thickness (IMT), common
carotid plaque, arterial stiffness, and coronary artery calciﬁca-
tion [7–10].
Vascular access dysfunction is a major cause of morbidity
and hospitalization in HD patients. The main cause of arter-
iovenous dysfunction is thrombosis, secondary to dispropor-
tionate intimal hyperplasia in the venous outﬂow tract.
However, atherosclerotic lesions including calciﬁcation may
also cause arterial problems and vascular stiffness. Calciﬁed
arteries might not remodel appropriately to provide an ade-
quate ﬂow to the ﬁstula [11]. And extensive calciﬁcation in the
intima and media of venous segment might result in reduced
venous compliance by limiting the outward remodeling of
arteriovenous ﬁstula (AVF) maturation [11,12]. There have
been only a few studies that ascertained the association
between atherosclerosis and vascular access failure (VAF) [13].
Our study objectives were: (1) to analyze clinical features of
atherosclerosis in HD patients; and (2) to assess the relation-
ship between atherosclerosis and vascular access failure.Table 1. Clinical and biochemical characteristics of the study
patientsMethods
Participants
Between May 2012 and November 2012, we evaluated 60
HD patients with AVFs and grafts. Each participant gave
informed consent to participate in the study. This study
protocol was approved by the Soonchunhyang University
Hospital Institutional Review Board (Bucheon, South Korea;
SCHBC-IRB-2012-65). The enrolled patients received 12–
15 hours of HD each week by using a bicarbonate dialysate.
The clinical history of the patients was obtained from their
medical records. CIMT measurement was performed on the
day of HD. Carotid atherosclerosis was deﬁned as a CIMT
Z0.9 mm or the incidence of plaques.
AVF failure episodes were deﬁned as a need for percuta-
neous transluminal angioplasty and/or surgery, and each
episode was recorded.Characteristics Value
Age (y) 54.52710.63
Sex (M/F) 36/24 (60.0/40.0)
BMI (kg/m2) 22.63 (202.485–246.62)
Systolic blood pressure (mmHg) 134.70719.327
Diastolic blood pressure (mmHg) 76.105713.22
Underlying disease
Hypertension 51 (80.00)
Diabetes mellitus 26 (43.33)
Angina 7 (11.67)
Peripheral arterial occlusive disease 9 (15.00)
Stroke 4 (6.67)
Smoking 17 (28.33)
Albumin (g/dL) 3.90 (3.60–4.20)
Calcium (mg/dL) 8.60 (3.60–9.10)
Phosphate (mg/dL) 4.80 (4.253–6.253)
PTH (pg/mL) 122.30 (52.40–210.70)
FGF23 (pg/mL) 1532.12 (423.325–2122.56)
Duration of hemodialysis (mo) 52.00 (20.30–85.50)
Duration of access survival (mo) 26.00 (6.80–60.00)
Duration from hemodialysis to ﬁrst
access revision (mo)
17.00 (2.00–52.00)
Data are presented as mean7SD, n (%) or median (IQR).
BMI, body mass index; FGF, ﬁbroblast growth factor; IQR, interquartile
range; PTH, parathyroid; SD, Standard deviation.CIMT measurement
CIMT was measured prior to or during HD by a single
nephrologist who used B-mode ultrasonography [LOGIQ e
ultrasound system (GE Healthcare, Milwaukee, WI, USA)] with
a high-resolution 4–12 MHz imaging transducer. For the car-
otid artery examination, all participants were instructed to lay
supine with their necks extended in mild lateral rotation. The
right common carotid artery, bifurcation, and internal carotid
artery at the bulb level were scanned for plaque and measured
for IMT. The areas measured were 10 mm and 20 mm after the
carotid bifurcation in the right internal carotid artery.
Then, the mean IMT was obtained by averaging the two
measurements. The CIMT was deﬁned as the distance from
the leading edge of the ﬁrst echogenic line (lumen–intima
interface) to the leading edge of the second line (media–
adventitia interface).
When plaque was present in the segment used for measur-
ing the mean IMT, the plaque thickness was averaged to the
mean IMT measurement. Plaque was designated as a focal
intima–media thickening of Z1.1 mm.Laboratory measurements
Serum intact ﬁbroblast growth factor (FGF) 23 was mea-
sured using a two-site monoclonal antibody enzyme-linked
immunosorbent assay (ELISA) system (ELISA assay; Kainos
Laboratory, Tokyo, Japan; reference range¼8.2–54.3 pg/mL).
All other laboratory variables, including calcium, phosphate,
and intact parathyroid hormone (PTH), were determined using
conventional laboratory techniques after 8-hour fasting. The
level of glycosylated hemoglobin (HbA1c) was determined in
diabetic patients. Fasting blood samples were collected on the
day of dialysis just prior to starting the dialysis.
Statistical analysis
We used the SPSS software for all analyses (version 14.0;
SPSS Inc., Chicago, IL, USA). In Tables 1 and 2, the demographic
and hemodynamic data are presented as mean7standard
deviation (SD), median (interquartile range), or the percentage
of the total. The multiple regression model was used for the
correlation analysis of CIMT and variables. The difference in
frequency was tested using Pearson Chi-square analysis. Dif-
ferences between the groups regarding the numerical data
were assessed using the Mann–Whitney test. The Kaplan–
Meier method was used to evaluate the time-to-event dis-
tribution. We calculated adjusted hazard ratios (HRs) with 95%
conﬁdence intervals (95% CIs) for patency loss using Cox
regression analysis. A P value o0.05 was considered statisti-
cally signiﬁcant.Results
Patient characteristics
The baseline demographic and the clinical and biochem-
ical parameters of the 60 patients are reported in Table 1. The
Table 2. Comparison of clinical characteristics between individuals with atherosclerosis and without atherosclerosis
Characteristics Patients with atherosclerosis
(IMTZ0.9 mm) (n¼14)
Patients without atherosclerosis
(IMTo0.9 mm) (n¼46)
P
Age (y) 62.21711.25 52.1779.36 0.008
Diabetes mellitus 9 (64.293) 17 (37.00) 0.071
Cardiovascular disease 3 (21.43) 4 (8.70) 0.337
Peripheral arterial disease 4 (28.576) 5 (10.879) 0.193
Stroke 1 (7.14) 3 (6.52) 1.000
ESR (mm/h) 42.50 (24.50–120.00) 31.00 (10.00–66.00) 0.054
CRP (mg/dL) 0.25 (0.13–1.28) 0.13 (0.06–0.55) 0.209
HbA1C 5.80 (5.15–6.45) 7.50 (6.10–8.90) 0.004
Total cholesterol (mg/dL) 135.50 (110.50–159.75) 121.00 (109.00–162.25) 0.727
HDL-cholesterol (mg/dL) 37.00 (30.00–45.00) 42.00 (36.00–50.00) 0.141
LDL-cholesterol (mg/dL) 93.00 (57.50–107.00) 60.00 (48.50–84.25) 0.063
Triglycerides (mg/dL) 129.00 (69.50–146.00) 75.50 (48.75–114.50) 0.081
Albumin (g/dL) 3.75 (3.28–4.00) 3.90 (3.60–4.20) 0.079
Calcium (mg/dL) 8.30 (7.55–9.00) 8.70 (8.20–9.10) 0.195
Phosphate (mg/dL) 4.55 (3.65–5.80) 4.85 (4.48–6.38) 0.173
PTH (pg/mL) 82.56 (46.04–137.50) 174.95 (66.57–286.45) 0.057
FGF23 (pg/mL) 1686.17 (187.68–2122.57) 1415.10 (448.07–2122.57) 0.906
AVF 10 (71.43) 32 (69.576) 1.000
Incidence of access failure 7 (50.00) 24 (52.172) 0.887
Duration from hemodialysis to ﬁrst access
failure (mo)
3.00 (1.00–24.00) 23.00 (2.25–60.00) 0.076
Data are presented as mean7SD, n (%) or median (IQR).
AVF, arteriovenous ﬁstula; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; FGF, ﬁbroblast growth factor; HbA1C, glycosylated
hemoglobin; HDL, high-density lipoprotein; IMT, intima-media thickness; IQR, interquartile range; LDL, low-density lipoprotein; PTH, parathyroid
hormone; SD, standard deviation.
Table 3. Correlations between IMT and laboratory ﬁndings by
multiple regression analysis
Characteristics β P
Agen 0.011 0.064
BMI† 0.116 0.333
Systolic Blood pressure‡ 0.153 0.334
Diastolic Blood pressure‡ 0.008 0.081
Park et al / Atherosclerosis in HD patients 179mean age of the patients in this study was 54.5710.6 years,
and 60% of the patients were male. Hypertension was present
in 51 (85%), diabetes mellitus in 26 (43.3%), and smoking in 17
(28.3%) of the patients. The mean duration of HD was 65.787
60.56 months. The mean access survival was 62.15754.57
months. In patients with access failure, the mean time to ﬁrst
access failure was 34.90744.57 months.ESR‡ 0.005 0.006*
HbA1C‡ 0.383 0.409
CRP‡ 0.010 0.869
Total cholesterol‡ 0.601 0.482
HDL-cholesterol‡ 7.988E5 0.983
LDL-cholesterol‡ 0.003 0.179
Triglycerides‡ 0.000 0.703
Albumin‡ 0.049 0.713
Calcium‡ 0.050 0.273
Phosphate‡ 0.039 0.284
PTH‡ 0.000 0.295
FGF23‡ 7.441E5 0.244
n Adjusted for sex.
† Adjusted for age, sex, hypertension, diabetes mellitus, cardiovascular
disease.
‡ Adjusted for age, sex, BMI, hypertension, diabetes mellitus, cardiovas-
cular disease.
BMI, body mass index; CRP, C-reactive protein; ESR, erythrocyte
sedimentation rate; FGF, ﬁbroblast growth factor; HbA1C, glycosylated
hemoglobin; HDL, High-density lipoprotein; IMT, intima-media thick-
ness; LDL, Low density lipoprotein; PTH, parathyroid hormone.CIMT and factors associated with CIMT
The median CIMT was 0.8170.47 mm (range, 0.35–
2.50 mm). Of the 60 patients, 12 had plaques. Based on the
deﬁnition of atherosclerosis (CIMTZ0.9 mm), we divided the
patients into two groups: atherosclerosis group (n¼14) and
nonatherosclerosis group (n¼46) [14]. In the atherosclerosis
group, 10 patients had native AVF (71.4%, 10 lower arm),
whereas 32 patients were dialyzed via native AVF in the
nonatherosclerosis group (69.6%, 31 lower arm, 1 upper arm).
There was no signiﬁcant difference in terms of access type
(P¼1.00). Patients in the atherosclerosis group were older
than those in the nonatherosclerosis group. Furthermore,
patients in the atherosclerosis group had lower levels of
HbA1C and a higher frequency of plaques (Table 2). The
atherosclerosis group had higher levels of total cholesterol,
low-density lipoprotein cholesterol, and triglyceride, and a
lower level of high-density lipoprotein cholesterol and albu-
min than the nonatherosclerosis group, but the differences
were not statistically signiﬁcant. The inﬂammatory markers,
such as erythrocyte sedimentation rate (ESR) and C-reactive
protein (CRP), were also higher in the atherosclerosis group,
but again did not reach statistical signiﬁcance.
Of these factors, CIMT showed a positive correlation with
ESR (β¼0.005, P¼0.006; Table 3). Age showed a positive
correlation but not a statistically signiﬁcant relationship with
CIMT (β¼0.011, P¼0.064).Impact of atherosclerosis on VAF
Table 4 shows the adjusted HRs of the risk factors for
primary access patency. Patients with atherosclerosis showed
much shorter durations of access patency than those in the
nonatherosclerosis group (HR¼2.822, CI 1.113–7.156; P¼0.029).
Kaplan–Meier curves also showed shorter access patency
in the atherosclerosis group with statistical signiﬁcance
(P¼0.027, Fig. 1). Furthermore, being overweight was associated
with a 2.47-fold (95% CI 1.101–5.548, P¼0.028) increased
Table 4. Correlations between vascular access failure and laboratory ﬁndings
Characteristics Duration from hemodialysis to ﬁrst access failure
P HR (95% CI)
Agen Z 65 versuso65y 0.615
Sex† Female versus male 0.329
CIMT‡ CIMT Z0.09 versuso0.09 mm 0.029 2.822 (1.113–7.156)
Hypertension§ Yes versus No 0.674
Diabetes mellitus║ Yes versus No 0.784
Angina‡ Yes versus No 0.515
Peripheral arterial occlusive disease‡ Yes versus No 0.765
Stroke‡ Yes versus No 0.067
BMI‡ BMIZ23 versuso23 kg/m2 0.028 2.472 (1.101–5.548)
Leukocytosis‡ WBCZ104 versuso104 /μL 0.259
CRP‡ r 0.05 versus40.05 mg/dL 0.938
Hypercholesterolemia‡ Total cholesterolZ200 versuso200 mg/dL 0.252
n Adjusted for sex.
† Adjusted for age.
‡ Adjusted for age, sex, history of hypertension, diabetes mellitus.
§ Adjusted for age, sex, history of diabetes mellitus.
║ Adjusted for age, sex, history of hypertension.
BMI, body mass index; CI, conﬁdence interval; CIMT, carotid intima–media thickness; CRP, C-reactive protein; HR, hazard ratio; WBC, white blood cell.
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access patency and hypertension, diabetes mellitus, and CRP
(Table 4).Figure 1. Kaplan-Meier curves for access patency. Atherosclerosis
group had shorter access patency than non-atherosclerosis group
(p¼0.027).Discussion
Cardiovascular disease due to accelerated atherosclerosis is
the principal cause of morbidity and mortality in HD patients
[15]. An increased CIMT is regarded as an early sign of
atherosclerosis. CIMT is related to cardiovascular disease
affecting distant vascular beds, such as the cerebral, periph-
eral, and coronary artery vascular beds [16]. High-resolution
B-mode ultrasonography of the carotid arteries provides mea-
sures of IMT and atherosclerotic plaques. This is an inexpen-
sive, mobile, and easily available method, with few, if any,
complications or side effects [17].
In previous studies, HD patients were reported to show
advanced atherosclerosis in the carotid arteries compared with
age-matched healthy control participants [4,18]. Moreover,
increased CIMT might be an independent predictor of cardio-
vascular mortality in the HD population [19]. In Korea, Song
et al [20] studied the association of inﬂammatory markers and
CIMT in continuous ambulatory peritoneal dialysis patients. To
our knowledge, the present study is the ﬁrst to evaluate the
CIMT in Korean HD patients by using high-resolution B-mode
ultrasound.
The mean IMT of the participants in the present study was
0.8170.47 mm, whereas the reported mean CIMT of healthy
people in Korea is 0.6870.17 mm [21]. Increased IMT is
associated with age, hypercholesterolemia, hypertension, and
smoking. Hypertension has been associated with increased
CIMT [13,14,22]. However, we found no such link with blood
pressure in our patients when we compared the blood pres-
sure between the atherosclerosis and the nonatherosclerosis
groups. In our study, we did not analyze the effect of
antihypertensive medications, and the number of the study
patients was small. Moreover, blood pressure in HD patients
often varies because of autonomic neuropathy [22]. Therefore,
it is difﬁcult to evaluate the correlation between blood
pressure and atherosclerosis in HD patients.Stenvinkel et al [18] reported that atherosclerosis in
advanced chronic renal disease was caused by the synergistic
effects of malnutrition, inﬂammation, oxidative stress, and
genetic components. Our study showed that the group with
atherosclerosis had higher levels of ESR and CRP; however,
statistical signiﬁcance was not reached.
Secondary hyperparathyroidism with hyperphosphatemia
and increased calcium-phosphate product is a cause of
vascular calciﬁcation [23]. PTH causes an increase of endothe-
lial microparticles [24], and the increased endothelial micro-
particles may cause changes in the arterial structure,
including atherosclerosis [25,26]. In our study, IMT showed
no association with calcium, phosphate, and PTH levels.
This may be because our study did not analyze medications,
including vitamin D analogs, or include a history of
parathyroidectomy.
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with increased morbidity and hospitalization [27]. The main
cause of VAF is stenosis at the arteriovenous anastomosis due
to abnormal neointimal proliferation and extracellular
matrix deposition [28]. However, arterial problems with ather-
osclerotic lesions and vascular calciﬁcation also cause VAF
[11,29]. Campos et al [30] noted that causes of early AVF failure
may include atherosclerotic disease. Furthermore, a recent
study suggested that well-known risk factors for atherosclero-
sis such as cardiovascular disease and fetuin-A levels might
play an important role in the development of stenotic lesions
in AVFs in dialysis patients [13]. Hofstra et al [31] stated that
stenotic lesions in AVFs and peripheral bypass grafts had
atherosclerotic histopathology. Chen et al [32] reported that
HD patients with peripheral arterial disease had higher
VAF rates.
Previous studies on the risk factors of arteriovenous dys-
function have shown conﬂicting results [13,33–35]. Clinical
risk factors are increased age, female gender, diabetes, stroke,
cardiovascular disease, and prior catheter use [13,36–38]. In
this study, we showed that the duration of access patency had
an inverse relationship with atherosclerosis and body mass
index (BMI). Our ﬁndings suggest that increased CIMT may be
one of the factors of access failure in HD patients. Kim et al
[39] found that increased radial artery IMT is closely associated
with early failure of radiocephalic AVF in HD patients. Athero-
sclerosis may cause luminal narrowing and loss of vascular
elasticity, which increases arterial stiffness. These factors
restrict the outward remodeling of AVF maturation [11,39].
However, further study is required to evaluate the impact of
atherosclerosis on primary access failure.
The relationship between obesity and vascular access
outcomes remains controversial. However, many studies sug-
gested that increased BMI is a risk factor for the absence of a
functioning ﬁstula [36,38,40–42]. Marchi et al [37] suggested
pathogenetic mechanisms for ﬁstula failure in the obese
subpopulation. They demonstrated that patients with ﬁstula
dysfunction have a higher level of monocyte chemoattractant
protein-1 (MCP-1), interleukin-6 (IL-6), hyperinsulinemia,
hyperlipidemia, plasminogen activator inhibitor type-1
(PAI-1), and factor VII than patients without ﬁstula dysfunction
[37]. We know that neointimal hyperplasia is primarily
responsible for primary and secondary ﬁstula failure and that
MCP-2, IL-6, and tumor necrosis factor-α regulate smooth
muscle migration and endothelial dysfunction. There are
increased levels of these cytokines, hyperinsulinemia and
dyslipidemia, as well as upregulation of PAI-1 in obese patients
[37,43]. Plumb et al [40] observed that excess axillary tissue
in obese patients resulted in compression of the venous
outﬂow of the arm in the adducted position, suggesting a
potential cause of this HD vascular access failure [40]. It could
be another explanation to early failure in patients with
high BMI.
Although not mentioned in the results, HbA1C was sig-
niﬁcantly lower in the group with atherosclerosis. This result is
related to the treatment condition of diabetic patients. In the
atherosclerosis group, 50% of diabetic patients were well
controlled (HbA1Co6.0%) without treatment, whereas in the
nonatherosclerosis group, 25% of diabetic patients were well
controlled without treatment. Recent studies reported that
HbA1C and carotid IMT have a positive relationship [44]. We
think that the discrepancy between this study and the pre-
vious studies is attributable to the small number of the studysample including diabetic patients. Thus, further large-scale
studies are required to verify this issue.
This study has several limitations. First, this study was
performed only on a minimum number of patients, as all
participants came from a single regional hospital. Second, we
measured the intima thickness only in the right common
carotid artery. Chatzizisis et al [45] showed that the left carotid
IMT is more susceptible to atherosclerotic disease. Third, we
did not include the patients’ medications and possible history
of parathyroidectomy in our analysis.
In conclusion, this is the ﬁrst report of the clinical char-
acteristics of atherosclerosis in Korean HD patients. This study
shows that atherosclerosis is associated with older age. More-
over, vascular access patency is negatively correlated with
CIMT and BMI. We recommend that the vascular access
monitoring be performed more carefully in HD patients with
atherosclerosis and overweight.Conﬂict of interest
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